Adding Microfluidic Modulation Spectroscopy to your Toolbox: A Deeper Dive into Protein Characterization for Drug Discovery

Abtract

Microfluidic Modulation Spectroscopy (MMS) transforms biophysical characterization by enabling sensitive, low-volume protein analysis for drug discovery. Traditional tools such as SDS-PAGE, SEC, DSF, SPR, and NMR often miss subtle structural changes or need large sample volumes and complex workflows. MMS combines a quantum-cascade laser with a microfluidic optical cell to deliver hands-free secondary-structure analysis across a wide concentration range. As shown in the SOP, researchers can analyze as little as 50 µg of protein in a 96-well plate, quantify samples from 5 mg/mL to 0.25 mg/mL, confirm quality with normalized spectra and R² > 0.99, and work directly in native buffers with minimal preparation.

MMS also reveals stability and structural changes essential to drug development. It tracks alpha-helix–to-beta-sheet transitions, calculates percent similarity across conditions, and highlights ligand-binding effects on stability under thermal stress. Built-in tools—such as second-derivative analysis, similarity scoring, and color-coded outputs—accelerate interpretation, reduce variability, and improve reproducibility. By closing gaps left by traditional techniques, MMS streamlines workflows and supports faster, evidence-based decisions in therapeutic protein characterization.